Summary
Protamine is an effective inhibitor of the various activated forms of adenylate cyclase of liver plasma membranes. Inhibition of adenylate cyclase may account for its toxic but not its antitumor effects.
References
Muggleton, P.W., Mac Laren, J.G., and Kyke, W.S.C., Lancet1 (1964) 409.
Csaba, G., Acs, Th., Horvath, C., and Kapa, E., Br. J. Cancer14 (1960) 367.
Lutton, A., Lancet1 (1964) 768.
Hughes, L. E., Lancet1 (1964) 408.
Taylor, S., and Folkman, J., Nature297 (1982) 307.
Kiss, Z., Eur. J. Biochem.95 (1979) 607.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J., J. biol. Chem.193 (1951) 265.
Kiss, Z., Biochem. Pharmac.29 (1980) 3203.
Ross, E.M., and Gilman, A. G., A. Rev. Biochem.49 (1980) 533.
Johnson, G.S., and Mukku, e V.R., J. biol. Chem.254 (1979) 95.
Burger, M.M., Bombik, B.M., Breckenridge, B. McL., and Sheppard, J.R., Nature, New Biol.239 (1972) 123.
Smets, L.A., Nature New Biol.239 (1972) 123.
Froehlich, J. E., and Rackmaler, M., J. Cell Biol.55 (1972) 19.
Cho-Chung, Y.S., and Gullino, P.M., Science183 (1974) 87.
Coffino, P., Gray, J. W., and Tomkins, G.M., Proc. natl Acad. Sci. USA72 (1975) 878.
Pastan, I., Johnson, G.S., and Anderson, W.B., A. Rev. Biochem.44 (1975) 491.
Sheppard, J.R., Nature New Biol.236 (1972) 14.
Rein, A., Carchman, R.A., Johnson, G.S. and Pastan, I., Biochem. biophys. Res. Commun.52 (1973) 899.
Miller, Z., Lovelace, E., Gallo, M., and Pastan, I., Science190 (1975) 1213.
Tisdale, M.J., and Phillips, B.J., Exp. Cell Res.99 (1976) 63.
Anderson, W.B., Johnson, G.S., and Pastan, I., Proc. natl Acad. Sci. USA70 (1973) 1055.
Hsie, A. W., and Puch, T.T., Proc. natl Acad. Sci. USA68 (1971) 358.
Sheppard, J.R., Proc. natl Acad. Sci. USA68 (1971) 1316.
Weber, M.J., J. biol. Chem.248 (1973) 2978.
Bodwin, S.J., and Cho-Chung, Y.S., Cancer Lett.3 (1977) 289.
Tisdale, M.J., Cancer Treatm. Rev.6 (1979) 1.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kiss, Z., Zamfirova, R. Protamine inhibits adenylate cyclase activity: a possible reason for the toxicity of protamine. Experientia 39, 1381–1382 (1983). https://doi.org/10.1007/BF01990114
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01990114